Abstract
Children with sickle cell disease, a chronic hemolytic anemia, present with a wide variety of neurological syndromes, including ischemic and hemorrhagic stroke, transient ischemic attacks, 'soft neurological signs', seizures, headache, coma, visual loss, altered mental status, cognitive difficulties, and covert or 'silent' infarction. Those with ischemic stroke usually have stenosis or occlusion of the distal internal carotid and proximal middle cerebral arteries. Indefinite transfusion prevents recurrence in most patients who have had a stroke, and can prevent first stroke in those with high transcranial Doppler velocities. High white cell count, low hemoglobin and oxyhemoglobin desaturation predict neurological complications. Other risk factors for overt ischemic stroke include hypertension, previous transient ischemic attack, covert infarction and chest crisis. For hemorrhagic stroke, aneurysms are common in adults but not children, who often present with hypertension after transfusion or corticosteroids. Seizures are particularly common in patients with cerebrovascular disease and covert infarction; the latter is also associated with hyposplenism and infrequent pain. Factors associated with cognitive difficulties include thrombocytosis, infarction, large-vessel disease, and perfusion abnormality on neuroimaging. As well as investigating the role of genes and the possibility that hydroxyurea or blood pressure control reduce neurological complications, we should explore the modifiable effects of poor nutrition, chronic infection, hemolysis and oxyhemoglobin desaturation on stroke risk.
Key Points
-
Neurological complications of sickle cell disease (SCD) include transient ischemic attacks, seizures and covert infarction, as well as ischemic and hemorrhagic stroke
-
Low hemoglobin, high white cell count and oxyhemoglobin desaturation are risk factors for neurological complications in SCD
-
High blood pressure is associated with ischemic and hemorrhagic stroke in SCD
-
Ischemic stroke secondary to stenotic disease of the intracranial large vessels might be predicted using transcranial Doppler ultrasound, and is preventable with lifelong blood transfusion
-
Trials of prevention of primary and secondary infarction by regular blood transfusion, hydroxyurea and overnight respiratory support are ongoing
-
The role of exposure from infancy to chronic infection, hemolysis, poor nutrition and oxyhemoglobin desaturation in determining the risk of neurological complications in SCD should be explored
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Scothorn DJ et al. (2002) Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr 140: 348–354
Hulbert ML et al. (2006) Exchange blood transfusion compared with simple transfusion for first overt stroke is associated with a lower risk of subsequent stroke: a retrospective cohort study of 137 children with sickle cell anemia. J Pediatr 149: 710–712
Ohene-Frempong K et al. (1998) Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 91: 288–294
Ganesan V et al. (2003) Investigation of risk factors in children with arterial ischemic stroke. Ann Neurol 53: 167–173
Earley CJ et al. (1998) Stroke in children and sickle-cell disease. Neurology 51: 169–176
Mercuri E et al. (1995) Neurological 'soft' signs may identify children with sickle cell disease who are at risk for stroke. Eur J Pediatr 154: 150–156
Melek I et al. (2006) Neurological soft signs as the stroke risk in sickle cell disease. Tohoku J Exp Med 209: 135–140
Prengler M et al. (2005) Sickle cell disease: ischemia and seizures. Ann Neurol 58: 290–302
Huttenlocher PR et al. (1984) Cerebral blood flow in sickle cell cerebrovascular disease. Pediatrics 73: 615–621
Kirkham FJ et al. (2001) Perfusion MR abnormalities in patients with sickle cell disease: relation to symptoms, infarction and cerebrovascular disease. Ann Neurol 49: 477–485
Prengler M et al. (2006) Sickle cell disease and electroencephalogram hyperventilation. Ann Neurol 59: 214–215
Kirkham FJ et al. (2001) Nocturnal hypoxaemia and central-nervous-system events in sickle-cell disease. Lancet 357: 1656–1659
Vichinsky EP et al. (2000) Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med 342: 1855–1865
Henderson JN et al. (2003) Reversible posterior leukencephalopathy syndrome and silent cerebral infarcts are associated with acute chest syndrome in sickle cell disease. Blood 101: 415–419
Lee KH et al. (2002) Unusual encephalopathy after acute chest syndrome: acute necrotizing encephalitis. J Pediatr Hematol Oncol 24: 585–588
Bakhshi S et al. (2002) Acute encephalopathy with parvovirus B19 infection in sickle cell disease. Arch Dis Child 87: 541–542
Wierenga KJ et al. (2001) Cerebrovascular complications and parvovirus infection in homozygous sickle cell disease. J Pediatr 139: 438–442
Kimmelstiel P (1948) Vascular occlusion and ischemic infarction in sickle cell disease. Am J Med Sci 216: 11–19
Makani J (2004) Stroke in sickle cell disease in Africa: case report. East Afr Med J 81: 657–659
Strouse JJ et al. (2006) Primary hemorrhagic stroke in children with sickle cell disease is associated with recent transfusion and use of corticosteroids. Pediatrics 118: 1916–1924
Horton DP et al. (1995) Nontraumatic fat embolism syndrome in sickle cell anemia. Pediatr Neurol 12: 77–80
Coley SC et al. (1999) Quantitative MR diffusion mapping and cyclosporine-induced neurotoxicity. AJNR Am J Neuroradiol 20: 1507–1510
Gadian DG et al. (2000) Diffusion and perfusion magnetic resonance imaging in childhood stroke. J Child Neurol 15: 279–283
van Mierlo TD et al. (2003) An unconscious girl with sickle cell disease. Lancet 361: 136
Sébire G et al. (2005) Venous sinus thrombosis in children. Brain 128: 477–489
Powars D et al. (1990) Delayed intracranial hemorrhage following cerebral infarction in sickle cell anemia. J Assoc Acad Minor Phys 1: 79–82
Balkaran B et al. (1992) Stroke in a cohort of patients with homozygous sickle cell disease. J Pediatr 120: 360–366
Pegelow CH et al. (2002) Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood 99: 3014–3018
Bernaudin F et al. (2000) Multicenter prospective study of children with sickle cell disease: radiographic and psychometric correlation. J Child Neurol 15: 333–343
Saunders DE et al. (2001) MRI in children with sickle cell disease without overt stroke. Dev Med Child Neurol 43 (Suppl 90): 27
Baldeweg T et al. (2006) Detecting white matter injury in sickle cell disease using voxel-based morphometry. Ann Neurol 59: 662–672
Kinney TR et al. (1999) Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. Pediatrics 103: 640–645
DeBaun MR et al. (1998) Cognitive screening examinations for silent cerebral infarcts in sickle cell disease. Neurology 50: 1678–1682
Watkins KE et al. (1998) Cognitive deficits associated with frontal lobe infarction in children with sickle cell disease. Dev Med Child Neurol 40: 536–543
Hogan AM et al. (2006) Impact of frontal white matter lesions on performance monitoring: ERP evidence for cortical disconnection. Brain 129: 2177–2188
Hogan AM et al. (2006) An exploratory study of physiological correlates of neurodevelopmental delay in infants with sickle cell anaemia. Br J Haematol 132: 99–107
Wang W et al. (2001) Neuropsychologic performance in school-aged children with sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr 139: 391–397
Hogan AM et al. (2005) Intellectual decline in children with moyamoya and sickle cell anaemia. Dev Med Child Neurol 47: 824–829
Schatz J and Buzan R (2006) Decreased corpus callosum size in sickle cell disease: relationship with cerebral infarcts and cognitive functioning. J Int Neuropsychol Soc 12: 24–33
Koshy M et al. (1990) Vascular lesions in the central nervous system in sickle cell disease (neuropathology). J Assoc Acad Minor Phys 1: 71–78
Rothman SM et al. (1986) Sickle cell anemia and central nervous system infarction: a neuropathological study. Ann Neurol 20: 684–690
Garcia JH (1990) Thromosis of cranial veins and sinuses: brain parenchymal effects. In Cerebral Sinus Thrombosis: Experimental and Clinical Aspects, 27–38 (Eds Einhäupl K et al.) New York: Plenum Press
Di Roio C et al. (1997) Sickle cell anemia and internal cerebral vein thrombosis [French]. Ann Fr Anesth Reanim 16: 967–969
Connelly A et al. (1997) Diffusion weighted magnetic resonance imaging of compromised tissue in stroke. Arch Dis Child 77: 38–41
Pavlakis SG et al. (1988) Brain infarction in sickle cell anemia: magnetic resonance imaging correlates. Ann Neurol 23: 125–130
Adams RJ et al. (1988) Cerebral infarction in sickle cell anemia: mechanism based on CT and MRI. Neurology 38: 1012–1017
Preul MC et al. (1998) Intracranial aneurysms and sickle cell anemia: multiplicity and propensity for the vertebrobasilar territory. Neurosurgery 42: 971–977
Dobson SR et al. (2002) Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events. Blood 99: 3144–3150
Stockman JA et al. (1972) Occlusion of large cerebral vessels in sickle cell anemia. N Engl J Med 287: 846–849
Wiznitzer M et al. (1990) Diagnosis of cerebrovascular disease in sickle cell anemia by magnetic resonance angiography. J Pediatr 117: 551–555
Kandeel AY et al. (1996) Comparison of magnetic resonance angiography and conventional angiography in sickle cell disease: clinical significance and reliability. Neuroradiology 38: 409–416
Gillams AR et al. (1998) MRA of the intracranial circulation in asymptomatic patients with sickle cell disease. Pediatr Radiol 28: 283–287
Adams RJ et al. (1997) Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol 42: 699–704
Ganesan V et al. (2006) Recurrence after childhood ischemic stroke. Circulation 114: 2170–2177
Driscoll MC et al. (2003) Stroke risk in siblings with sickle cell anemia. Blood 101: 2401–2404
Hsu LL et al. (2003) Alpha thalassemia is associated with decreased risk of abnormal transcranial Doppler ultrasonography in children with sickle cell anemia. J Pediatr Hematol Oncol 25: 622–628
Kirkham FJ (2003) Is there a genetic basis for pediatric stroke? Curr Opin Pediatr 15: 547–558
Hoppe C et al. (2004) Gene interactions and stroke risk in children with sickle cell anemia. Blood 103: 2391–2396
Hebbel RP et al. (2005) Genetic influence on the systems biology of sickle stroke risk detected by endothelial gene expression [abstract #73]. Blood 106: 26A
Taylor JG 6th et al. (2002) Variants in the VCAM1 gene and risk for symptomatic stroke in sickle cell disease. Blood 100: 4303–4309
Sebastiani P et al. (2005) Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia. Nat Genet 37: 435–440
Kato GJ et al. (2006) Cerebrovascular disease associated with sickle cell pulmonary hypertension. Am J Hematol 81: 503–510
Kirkham FJ and Datta AK (2006) Hypoxic adaptation during development: relation to pattern of neurological presentation and cognitive disability. Dev Sci 9: 411–427
Pelidis MA et al. (1997) Successful treatment of life-threatening acute chest syndrome of sickle cell disease with venovenous extracorporeal membrane oxygenation. J Pediatr Hematol Oncol 19: 459–461
Steen RG et al. (1999) Subtle brain abnormalities in children with sickle cell disease: relationship to blood hematocrit. Ann Neurol 45: 279–286
Hogan AM et al. (2006) Physiological correlates of intellectual function in children with sickle cell disease: hypoxaemia, hyperaemia and brain infarction. Dev Sci 9: 379–387
Strouse JJ et al. (2006) Inverse correlation between cerebral blood flow measured by continuous arterial spin-labeling (CASL) MRI and neurocognitive function in children with sickle cell anemia (SCA). Blood 108: 379–381
Kral MC et al. (2003) Transcranial Doppler ultrasonography and neurocognitive functioning in children with sickle cell disease. Pediatrics 112: 324–331
Adams RJ et al. (1994) Alpha thalassemia and stroke risk in sickle cell anemia. Am J Hematol 45: 279–282
Adekile AD et al. (2002) Silent brain infarcts are rare in Kuwaiti children with sickle cell disease and high HbF. Am J Hematol 70: 228–231
Inwald DP et al. (2000) Platelet and leukocyte activation in childhood sickle cell disease: association with nocturnal hypoxaemia. Br J Haematol 111: 474–481
Setty BY et al. (2003) Hypoxemia in sickle cell disease: biomarker modulation and relevance to disease pathophysiology. Lancet 362: 1450–1455
Kirkham FJ et al. (2002) Nocturnal hypoxaemia and intracranial vessel turbulence on magnetic resonance angiography in children with sickle cell disease. Stroke 33: 345
Nordness ME et al. (2005) Asthma is a risk factor for acute chest syndrome and cerebral vascular accidents in children with sickle cell disease. Clin Mol Allergy 3: 2
Kirkham FJ et al. (2006) Trials in sickle cell disease. Pediatr Neurol 34: 450–458
Telfer P et al.: Clinical outcomes in children with sickle cell disease living in England: neonatal cohort in East London. Haematologica, in press
Quinn CT et al. (2004) Survival of children with sickle cell disease. Blood 103: 4023–4027
Zafeiriou DI et al. (2004) Central nervous system abnormalities in asymptomatic young patients with S beta-thalassemia. Ann Neurol 55: 835–839
Knight S et al. (1995) Factors associated with lowered intelligence in homozygous sickle cell disease. Arch Dis Child 73: 316–320
Kirkham FJ et al. (2000) Risk factors for cognitive problems in sickle cell disease. Dev Med Child Neurol 42 (Suppl 85): 48
Houston PE et al. (1997) Homocysteine in sickle cell disease: relationship to stroke. Am J Med 103: 192–196
van der Dijs FPL et al. (2002) Optimization of folic acid, vitamin B12 and vitamin B6 in pediatric patients with sickle cell disease. Am J Hematol 69: 239–246
Dhar M et al. (2003) Pernicious anemia with neuropsychiatric dysfunction in a patient with sickle cell anemia treated with folate supplementation. N Engl J Med 348: 2204–2207
King L et al. (2005) Iron deficiency anaemia in Jamaican children, aged 1–5 years, with sickle cell disease. West Indian Med J 54: 292–296
Morris CR et al. (2003) Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease? Am J Respir Crit Care Med 168: 63–69
Amer J et al. (2006) Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants. Br J Haematol 132: 108–113
Ohnishi ST and Ohnishi T (2001) In vitro effects of aged garlic extract and other nutritional supplements on sickle erythrocytes. J Nutr 131 (Suppl 3): S1085–S1092
Jaja SI et al. (2002) Blood pressure, hematologic and erythrocyte fragility changes in children suffering from sickle cell anemia following ascorbic acid supplementation. J Trop Pediatr 48: 366–370
Pokorski M and Marczak M (2003) Ascorbic acid enhances hypoxic ventilatory reactivity in elderly subjects. J Int Med Res 31: 448–457
Calabrese EJ (1982) Does consumption of mega-doses of ascorbic acid pose a hemolytic risk to persons with sickle cell trait and sickle cell anemia? Med Hypotheses 9: 647–649
Muskiet FA et al. (1991) Supplementation of patients with homozygous sickle cell disease with zinc, alpha-tocopherol, vitamin C, soybean oil, and fish oil. Am J Clin Nutr 54: 736–744
Riddington C and De Franceschi L. Drugs for preventing red blood cell dehydration in people with sickle cell disease. Cochrane Database of Systematic Reviews 2002, Issue 4. Art. No.: CD003426. DOI: 10.1002/14651858.CD003426
Adams RJ et al. (1992) Transcranial Doppler correlation with cerebral angiography in sickle cell disease. Stroke 23: 1073–1077
Abboud MR et al. (2004) Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study. Blood 103: 2822–2826
Clinical Effectiveness & Evaluation Unit (online November 2004) Stroke in childhood: clinical guidelines for diagnosis, management and rehabilitation. London: Royal College of Physicians [http://www.rcplondon.ac.uk/pubs/books/childstroke/childstroke_guidelines.pdf] (accessed 21 March 2007)
Portnoy BA and Herion JC (1972) Neurological manifestations in sickle-cell disease, with a review of the literature and emphasis on the prevalence of hemiplegia. Ann Intern Med 76: 643–652
Wood DH (1978) Cerebrovascular complications of sickle cell anemia. Stroke 9: 73–75
Powars D et al. (1978) The natural history of stroke in sickle cell disease. Am J Med 65: 461–471
Russell MO et al. (1984) Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. Blood 63: 162–169
Wilimas J et al. (1980) Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidents. J Pediatr 96: 205–208
Kirkham FJ and DeBaun MR (2004) Stroke in children with sickle cell disease. Curr Treat Options Neurol 6: 357–375
Pegelow CH et al. (1995) Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr 126: 896–899
Ware RE et al. (2004) Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy. J Pediatr 145: 346–352
DeBaun MR (2005) Hydroxyurea as secondary prevention for stroke in children with sickle cell anemia. J Pediatr 147: 560–561
Fryer RH et al. (2003) Sickle cell anemia with moyamoya disease: outcomes after EDAS procedure. Pediatr Neurol 29: 124–130
Vermylen C et al. (1998) Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplant 22: 1–6
Walters MC et al. (2000) Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report: multicenter investigation of bone marrow transplantation for sickle cell disease. Blood 95: 1918–1924
Locatelli F et al. (2003) Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 101: 2137–2143
Woodard P et al. (2005) Brain parenchymal damage after haematopoietic stem cell transplantation for severe sickle cell disease. Br J Haematol 129: 550–552
Steen RG et al. (2001) Improved cerebrovascular patency following therapy in patients with sickle cell disease: initial results in 4 patients who received HLA-identical hematopoietic stem cell allografts. Ann Neurol 49: 222–229
Bernaudin F et al. (2005) Long-term follow-up of pediatric sickle cell disease patients with abnormal high velocities on transcranial Doppler. Pediatr Radiol 35: 242–248
McQuaker IG et al. (1999) Coil embolization of cerebral aneurysms in patients with sickling disorders. Br J Haematol 106: 388–390
Adams RJ et al. (1998) Prevention of a First Stroke by Transfusions in Children with Sickle Cell Anemia and Abnormal Results on Transcranial Doppler Ultrasonography. N Engl J Med 339: 5–11
Adams RJ (2000) Lessons from the Stroke Prevention Trial in Sickle Cell Anemia (STOP) study. J Child Neurol 15: 344–349
Adams RJ et al. (2005) Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med 353: 2769–2778
Fullerton HJ et al. (2004) Declining stroke rates in Californian children with sickle cell disease. Blood 104: 336–339
Section on Hematology/Oncology Committee on Genetics (2002) Health supervision for children with sickle cell disease. Pediatrics 109: 526–535
National Health Service Antenatal and Newborn Screening Programmes (online October 2004) Sickle cell disease in childhood: standards and guidelines for clinical care [http://www.sickleandthal.org.uk/Documents/DETAILED_CLIN_Oct19.pdf] (accessed 21 March 2007)
Sweany JM et al. (2007) “Recurrent” posterior reversible encephalopathy syndrome: report of 3 cases—PRES can strike twice! J Comput Assist Tomogr 31: 148–156
Akpede GO and Airede AI (1993) Acute encephalopathy, hypertension and gram negative sepsis in sickle cell disease. West Afr J Med 12: 180–184
Sykes RM (1998) Sickle cell disease, pneumococcal meningitis and paraplegia with recovery. Ann Trop Paediatr 18: 63–64
Ammoumi AA et al. (1975) Spinal cord compression by extramedullary hemopoietic tissue in sickle cell anemia: case report. J Neurosurg 43: 483–485
Lewin P and Goodell RA Jr (1962) Post-operative blindness, with complete recovery, in a patient with sickle-cell anaemia. Br Med J 5316: 1373
Liem RI et al. (2007) Sudden onset blindness in sickle cell disease due to retinal artery occlusion. Pediatr Blood Cancer [doi: 10.1002/pbc.21152]
Henry M et al. (2004) Pseudotumor cerebri in children with sickle cell disease: a case series. Pediatrics 113: e265–e269
Segal L and Discepola M (2005) Idiopathic intracranial hypertension and sickle cell disease: two case reports. Can J Ophthalmol 40: 764–767
Palermo TM et al. (2005) Headache symptoms in pediatric sickle cell patients. J Pediatr Hematol Oncol 27: 420–424
Silva GS et al. (2006) Migraine-mimicking headache and sickle cell disease: a transcranial Doppler study. Cephalalgia 26: 678–683
Tsibulevskaya G et al. (1996) Sensorineural hearing loss in patients with sickle cell anaemia in Kenya. East Afr Med J 73: 471–473
Orchik DJ and Dunn JW (1977) Sickle cell anemia and sudden deafness. Arch Otolaryngol 103: 369–370
Acknowledgements
FJ Kirkham's work has been funded by the Wellcome Trust (0353521 B/92/2), Action Research and the Stroke Association (PROG 4), and has benefitted from research and development funding received from the National Health Service Executive.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Kirkham, F. Therapy Insight: stroke risk and its management in patients with sickle cell disease. Nat Rev Neurol 3, 264–278 (2007). https://doi.org/10.1038/ncpneuro0495
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpneuro0495
This article is cited by
-
Optimisation of T2 and T2* sequences in MRI for better quantification of iron on transfused dependent sickle cell patients
Scientific Reports (2021)
-
Imaging review of sickle cell disease for the emergency radiologist
Emergency Radiology (2021)
-
Sichelzellkrankheit
Der Internist (2020)
-
Headache and Facial Pain in Sickle Cell Disease
Current Pain and Headache Reports (2016)
-
Adverse neurological outcomes in Nigerian children with sickle cell disease
International Journal of Hematology (2012)